Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 61 Results Clear All
The Circuit—Gladstone Investigator Jennifer Doudna discusses the origins of CRISPR and where it's headed, other breakthroughs in gene editing and what Silicon Valley gets wrong about the future of biology.
Doudna Lab CRISPR/Gene Editing AI
An innovative chromatin-shredding technique shown to destroy cancer cells carrying a prevalent mutation while keeping healthy cells intact.
News Release Research (Publication) Doudna Lab CRISPR/Gene Editing Cancer
Genetic Engineering & Biotechnology News—Gladstone Investigator Jennifer Doudna and collaborators developed a CRISPR-based strategy that selectively destroys cancer cells with p53 mutations, opening a potential new path for treating some of the deadliest cancers.
Doudna Lab CRISPR/Gene Editing
Chemical & Engineering News—Gladstone Investigator Jennifer Doudna, the 2026 Priestley Medalist, shares how she struggled to find her way through school before achieving the greatest feats in science.
Gladstone Experts Doudna Lab
From fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab
The featured scientists include global leaders in gene editing, data science, and immunology.
Awards News Release Corces Lab Doudna Lab Marson Lab Pollard Lab Ye Lab
Innovative Genomics Institute—A team of researchers, including Gladstone Investigator Jennifer Doudna, reveal that viruses have evolved a surprisingly large and diverse set of enzymes specifically designed to destroy immune alarm signals from cells, helping them disable the host’s antiviral defenses.
Gladstone Experts Infectious Disease Doudna Lab
The striking findings of a new study could influence how gene therapies are designed for many genetic diseases.
News Release Research (Publication) Neurological Disease Conklin Lab Doudna Lab CRISPR/Gene Editing
Azalea Therapeutics—Gladstone Investigators Jennifer Doudna and Justin Eyquem founded a new company to advance next-generation genomic medicines.
Business Development Gladstone Experts Doudna Lab Eyquem Lab
The Atlantic (via Instagram)—In this short video clip, Gladstone Investigator Jennifer Doudna explains how vaccinations have been so successful that there's been a collective forgetting that diseases, including measles, used to kill people in fairly large numbers.
Gladstone Experts Doudna Lab
Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.
Awards Gladstone Experts Doudna Lab
Postdoc Jason Nomburg enjoys sci-fi novels, playing tennis, and walks through Golden Gate Park when he's not decoding the secrets of viral proteins.
Graduate Students and Postdocs Profile Doudna Lab
The featured scientists include global leaders in gene editing, systems biology, AI, and immunology.
Awards News Release Doudna Lab Krogan Lab Marson Lab Pollard Lab Ye Lab
Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.
Gladstone Experts Infectious Disease Doudna Lab
Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies
News Release Research (Publication) Data Science and Biotechnology Infectious Disease Doudna Lab CRISPR/Gene Editing
